Discover
ONC
BeOne Medicines AG
290.74
1 x 290.66
1 x 292.18
bid
ask
+
5.77
2.02%
1 @ 05:59 AM
289.99 -0.75 (0.26%)
| Ytd | -4.30% | |
| 1y | 19.00% |
283.32
day range
293.54
239.25
52 week range
385.22
| Open | 286.00 | Prev Close | 284.97 | Low | 283.32 | High | 293.54 | Mkt Cap | 30.16B |
| Vol | 338.98K | Avg Vol | 251.25K | EPS | 4.42 | P/E | 65.78 | Forward P/E | 29.93 |
| Beta | 0.49 | Short Ratio | 3.29 | Inst. Own | 32.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 290.02 | 200-d Avg | 316.24 | 1yr Est | 412.35 |
| Income Statement | |||
| Total Revenue | 1.51B | ||
| Revenues (USD) | 1.51B | ||
| Cost of Revenue | 167.22M | ||
| Gross Profit | 1.35B | ||
| Operating Expenses | 1.10B | ||
| Research and Development Expense | 541.22M | ||
| Selling, General and Administrative Expense | 555.10M | ||
| Operating Income | 249.90M | ||
| Interest Expense | 32.89M | ||
| Income Tax Expense | 31.86M | ||
| Net Income | 227.36M | ||
| Net Income Common Stock | 227.36M | ||
| Net Income Common Stock (USD) | 227.36M | ||
| Consolidated Income | 227.36M | ||
| Earnings per Basic Share | 0.16 | ||
| Earnings per Basic Share (USD) | 0.16 | ||
| Earnings per Diluted Share | 0.15 | ||
| Earning Before Interest & Taxes (EBIT) | 292.10M | ||
| Earning Before Interest & Taxes (USD) | 292.10M | ||
| Weighted Average Shares | 1.44B | ||
| Weighted Average Shares Diluted | 1.51B | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.79B | ||
| Cash and Equivalents (USD) | 4.79B | ||
| Trade and Non-Trade Receivables | 938.02M | ||
| Current Assets | 6.60B | ||
| Property, Plant & Equipment Net | 1.79B | ||
| Total Assets | 8.55B | ||
| Debt Current | 209.46M | ||
| Total Debt | 2.05B | ||
| Current Liabilities | 1.81B | ||
| Debt Non-Current | 1.84B | ||
| Total Liabilities | 3.79B | ||
| Accumulated Retained Earnings (Deficit) | -8.09B | ||
| Accumulated Other Comprehensive Income | -53.48M | ||
| Shareholders Equity | 4.76B | ||
| Shareholders Equity (USD) | 4.76B | ||
| Assets Non-Current | 1.95B | ||
| Total Debt (USD) | 2.05B | ||
| Goodwill and Intangible Assets | 61.68M | ||
| Inventory | 681.59M | ||
| Liabilities Non-Current | 1.98B | ||
| Trade and Non-Trade Payables | 423.55M | ||
| Tax Liabilities | 119.39M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 41.14M | ||
| Net Cash Flow from Financing | 68.63M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 243.78M | ||
| Capital Expenditure | -40.79M | ||
| Issuance (Purchase) of Equity Shares | 23.88M | ||
| Issuance (Repayment) of Debt Securities | 48.01M | ||
| Net Cash Flow from Investing | -45.51M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 27.00K | ||
| Net Cash Flow from Operations | 201.34M | ||
| Effect of Exchange Rate Changes on Cash | 19.32M | ||
| Share Based Compensation | 123.36M | ||